目次

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET INTRODUCTION
2.1. Definition
2.2. Scope of the Study
2.2.1. Research Objective
2.2.2. Assumptions
2.2.3.Limitations

3. RESEARCH METHODOLOGY
3.1. Overview
3.2. Data Mining
3.3. Secondary Research
3.4. Primary Research
3.4.1. Primary Interviews and Information Gathering Process
3.4.2.Breakdown of Primary Respondents
3.5. Forecasting Model
3.6. Market Size Estimation
3.6.1. Bottom-Up Approach
3.6.2. Top-Down Approach
3.7. Data Triangulation
3.8. Validation

4. MARKET DYNAMICS
4.1. Overview
4.2. Drivers
4.3. Restraints
4.4. Opportunities

5. MARKET FACTOR ANALYSIS
5.1. Value Chain Analysis
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining Power of Suppliers
5.2.2. Bargaining Power of Buyers
5.2.3. Threat of New Entrants
5.2.4. Threat of Substitutes
5.2.5. Intensity of Rivalry
5.3. COVID-19 Impact Analysis
5.3.1. Market Impact Analysis
5.3.2. Regional Impact
5.3.3. Opportunity and Threat Analysis

6. GLOBAL ORTHOMOLECULAR MEDICINE MARKET, BY PRODUCT TYPE
6.1. Overview
6.2. Infant Nutrition
6.3. Parenteral Nutrition
6.4. Enteral Nutrition

7. GLOBAL ORTHOMOLECULAR MEDICINE MARKET, BY FORM
7.1. Overview
7.2. Powder
7.3. Capsules

8. GLOBAL ORTHOMOLECULAR MEDICINE MARKET, BY DISTRIBUTION CHANNEL
8.1. Overview
8.2. Hospitals Pharmacies
8.3. Private clinics
8.4. Drug stores and retail pharmacy
8.5. E-commerce

9. GLOBAL ORTHOMOLECULAR MEDICINE MARKET, BY REGION
9.1. Overview
9.1. North America
9.1.1. US
9.1.2. Canada
9.2. Europe
9.2.1. Germany
9.2.2. France
9.2.3. UK
9.2.4. Italy
9.2.5. Spain
9.2.6. Rest of Europe
9.3. Asia-Pacific
9.3.1. China
9.3.2. India
9.3.3. Japan
9.3.4. South Korea
9.3.5. Australia
9.3.6. Rest of Asia-Pacific
9.4. Rest of the World
9.4.1. Middle East
9.4.2. Africa
9.4.3. Latin America

10. COMPETITIVE LANDSCAPE
10.1. Overview
10.2. Competitive Analysis
10.3. Market Share Analysis
10.4. Major Growth Strategy in the Global Orthomolecular Medicine Market,
10.5. Competitive Benchmarking
10.6. Leading Players in Terms of Number of Developments in the Global Orthomolecular Medicine Market,
10.7. Key developments and Growth Strategies
10.7.1. New Product Launch/Service Deployment
10.7.2. Merger & Acquisitions
10.7.3. Joint Ventures
10.8. Major Players Financial Matrix
10.8.1. Sales & Operating Income, 2022
10.8.2. Major Players R&D Expenditure. 2022

11. COMPANY PROFILES
11.1. Ortho Molecular Products
11.1.1. Company Overview
11.1.2. Financial Overview
11.1.3. Products Offered
11.1.4. Key Developments
11.1.5. SWOT Analysis
11.1.6. Key Strategies
11.2. Orthomol pharmazeutische Vertriebs GmbH
11.2.1. Company Overview
11.2.2. Financial Overview
11.2.3. Products Offered
11.2.4. Key Developments
11.2.5. SWOT Analysis
11.2.6. Key Strategies
11.3. NUTRICIA NORTH AMERICA
11.3.1. Company Overview
11.3.2. Financial Overview
11.3.3. Products Offered
11.3.4. Key Developments
11.3.5. SWOT Analysis
11.3.6. Key Strategies
11.4. Nutrihand, Inc
11.4.1. Company Overview
11.4.2. Financial Overview
11.4.3. Products Offered
11.4.4. Key Developments
11.4.5. SWOT Analysis
11.4.6. Key Strategies
11.5. NattoPharma
11.5.1. Company Overview
11.5.2. Financial Overview
11.5.3. Products Offered
11.5.4. Key Developments
11.5.5. SWOT Analysis
11.5.6. Key Strategies
11.6. Capsumed Pharm GmbH
11.6.1. Company Overview
11.6.2. Financial Overview
11.6.3. Products Offered
11.6.4. Key Developments
11.6.5. SWOT Analysis
11.6.6. Key Strategies

12. APPENDIX
12.1. References
12.2. Related Reports

LIST OF TABLES
TABLE 1 GLOBAL ORTHOMOLECULAR MEDICINE MARKET, SYNOPSIS, 2018-2032
TABLE 2 GLOBAL ORTHOMOLECULAR MEDICINE MARKET, ESTIMATES & FORECAST, 2018-2032 (USD BILLION)
TABLE 3 GLOBAL ORTHOMOLECULAR MEDICINE MARKET, BY PRODUCT TYPE, 2018-2032 (USD BILLION)
TABLE 4 GLOBAL ORTHOMOLECULAR MEDICINE MARKET, BY FORM, 2018-2032 (USD BILLION)
TABLE 5 GLOBAL ORTHOMOLECULAR MEDICINE MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 6 NORTH AMERICA: ORTHOMOLECULAR MEDICINE MARKET, BY PRODUCT TYPE, 2018-2032 (USD BILLION)
TABLE 7 NORTH AMERICA: ORTHOMOLECULAR MEDICINE MARKET, BY FORM, 2018-2032 (USD BILLION)
TABLE 8 NORTH AMERICA: ORTHOMOLECULAR MEDICINE MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 9 US: ORTHOMOLECULAR MEDICINE MARKET, BY PRODUCT TYPE, 2018-2032 (USD BILLION)
TABLE 10 US: ORTHOMOLECULAR MEDICINE MARKET, BY FORM, 2018-2032 (USD BILLION)
TABLE 11 US: ORTHOMOLECULAR MEDICINE MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 12 CANADA: ORTHOMOLECULAR MEDICINE MARKET, BY PRODUCT TYPE, 2018-2032 (USD BILLION)
TABLE 13 CANADA: ORTHOMOLECULAR MEDICINE MARKET, BY FORM, 2018-2032 (USD BILLION)
TABLE 14 CANADA: ORTHOMOLECULAR MEDICINE MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 15 EUROPE: ORTHOMOLECULAR MEDICINE MARKET, BY PRODUCT TYPE, 2018-2032 (USD BILLION)
TABLE 16 EUROPE: ORTHOMOLECULAR MEDICINE MARKET, BY FORM, 2018-2032 (USD BILLION)
TABLE 17 EUROPE: ORTHOMOLECULAR MEDICINE MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 18 GERMANY: ORTHOMOLECULAR MEDICINE MARKET, BY PRODUCT TYPE, 2018-2032 (USD BILLION)
TABLE 19 GERMANY: ORTHOMOLECULAR MEDICINE MARKET, BY FORM, 2018-2032 (USD BILLION)
TABLE 20 GERMANY: ORTHOMOLECULAR MEDICINE MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 21 FRANCE: ORTHOMOLECULAR MEDICINE MARKET, BY PRODUCT TYPE, 2018-2032 (USD BILLION)
TABLE 22 FRANCE: ORTHOMOLECULAR MEDICINE MARKET, BY FORM, 2018-2032 (USD BILLION)
TABLE 23 FRANCE: ORTHOMOLECULAR MEDICINE MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 24 ITALY: ORTHOMOLECULAR MEDICINE MARKET, BY PRODUCT TYPE, 2018-2032 (USD BILLION)
TABLE 25 ITALY: ORTHOMOLECULAR MEDICINE MARKET, BY FORM, 2018-2032 (USD BILLION)
TABLE 26 ITALY: ORTHOMOLECULAR MEDICINE MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 27 SPAIN: ORTHOMOLECULAR MEDICINE MARKET, BY PRODUCT TYPE, 2018-2032 (USD BILLION)
TABLE 28 SPAIN: ORTHOMOLECULAR MEDICINE MARKET, BY FORM, 2018-2032 (USD BILLION)
TABLE 29 SPAIN: ORTHOMOLECULAR MEDICINE MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 30 UK: ORTHOMOLECULAR MEDICINE MARKET, BY PRODUCT TYPE, 2018-2032 (USD BILLION)
TABLE 31 UK: ORTHOMOLECULAR MEDICINE MARKET, BY FORM, 2018-2032 (USD BILLION)
TABLE 32 UK: ORTHOMOLECULAR MEDICINE MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 33 REST OF EUROPE: ORTHOMOLECULAR MEDICINE MARKET, BY PRODUCT TYPE, 2018-2032 (USD BILLION)
TABLE 34 REST OF EUROPE: ORTHOMOLECULAR MEDICINE MARKET, BY FORM, 2018-2032 (USD BILLION)
TABLE 35 REST OF EUROPE: ORTHOMOLECULAR MEDICINE MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 36 ASIA-PACIFIC: ORTHOMOLECULAR MEDICINE MARKET, BY PRODUCT TYPE, 2018-2032 (USD BILLION)
TABLE 37 ASIA-PACIFIC: ORTHOMOLECULAR MEDICINE MARKET, BY FORM, 2018-2032 (USD BILLION)
TABLE 38 ASIA-PACIFIC: ORTHOMOLECULAR MEDICINE MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 39 JAPAN: ORTHOMOLECULAR MEDICINE MARKET, BY PRODUCT TYPE, 2018-2032 (USD BILLION)
TABLE 40 JAPAN: ORTHOMOLECULAR MEDICINE MARKET, BY FORM, 2018-2032 (USD BILLION)
TABLE 41 JAPAN: ORTHOMOLECULAR MEDICINE MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 42 CHINA: ORTHOMOLECULAR MEDICINE MARKET, BY PRODUCT TYPE, 2018-2032 (USD BILLION)
TABLE 43 CHINA: ORTHOMOLECULAR MEDICINE MARKET, BY FORM, 2018-2032 (USD BILLION)
TABLE 44 CHINA: ORTHOMOLECULAR MEDICINE MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 45 INDIA: ORTHOMOLECULAR MEDICINE MARKET, BY PRODUCT TYPE, 2018-2032 (USD BILLION)
TABLE 46 INDIA: ORTHOMOLECULAR MEDICINE MARKET, BY FORM, 2018-2032 (USD BILLION)
TABLE 47 INDIA: ORTHOMOLECULAR MEDICINE MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 48 AUSTRALIA: ORTHOMOLECULAR MEDICINE MARKET, BY PRODUCT TYPE, 2018-2032 (USD BILLION)
TABLE 49 AUSTRALIA: ORTHOMOLECULAR MEDICINE MARKET, BY FORM, 2018-2032 (USD BILLION)
TABLE 50 AUSTRALIA: ORTHOMOLECULAR MEDICINE MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 51 SOUTH KOREA: ORTHOMOLECULAR MEDICINE MARKET, BY PRODUCT TYPE, 2018-2032 (USD BILLION)
TABLE 52 SOUTH KOREA: ORTHOMOLECULAR MEDICINE MARKET, BY FORM, 2018-2032 (USD BILLION)
TABLE 53 SOUTH KOREA: ORTHOMOLECULAR MEDICINE MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 54 REST OF ASIA-PACIFIC: ORTHOMOLECULAR MEDICINE MARKET, BY PRODUCT TYPE, 2018-2032 (USD BILLION)
TABLE 55 REST OF ASIA-PACIFIC: ORTHOMOLECULAR MEDICINE MARKET, BY FORM, 2018-2032 (USD BILLION)
TABLE 56 REST OF ASIA-PACIFIC: ORTHOMOLECULAR MEDICINE MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 57 REST OF THE WORLD: ORTHOMOLECULAR MEDICINE MARKET, BY PRODUCT TYPE, 2018-2032 (USD BILLION)
TABLE 58 REST OF THE WORLD: ORTHOMOLECULAR MEDICINE MARKET, BY FORM, 2018-2032 (USD BILLION)
TABLE 59 REST OF THE WORLD: ORTHOMOLECULAR MEDICINE MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 60 MIDDLE EAST: ORTHOMOLECULAR MEDICINE MARKET, BY PRODUCT TYPE, 2018-2032 (USD BILLION)
TABLE 61 MIDDLE EAST: ORTHOMOLECULAR MEDICINE MARKET, BY FORM, 2018-2032 (USD BILLION)
TABLE 62 MIDDLE EAST: ORTHOMOLECULAR MEDICINE MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 63 AFRICA: ORTHOMOLECULAR MEDICINE MARKET, BY PRODUCT TYPE, 2018-2032 (USD BILLION)
TABLE 64 AFRICA: ORTHOMOLECULAR MEDICINE MARKET, BY FORM, 2018-2032 (USD BILLION)
TABLE 65 AFRICA: ORTHOMOLECULAR MEDICINE MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 66 LATIN AMERICA: ORTHOMOLECULAR MEDICINE MARKET, BY PRODUCT TYPE, 2018-2032 (USD BILLION)
TABLE 67 LATIN AMERICA: ORTHOMOLECULAR MEDICINE MARKET, BY FORM, 2018-2032 (USD BILLION)
TABLE 68 LATIN AMERICA: ORTHOMOLECULAR MEDICINE MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)

LIST OF FIGURES
FIGURE 1 RESEARCH PROCESS
FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL ORTHOMOLECULAR MEDICINE MARKET
FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL ORTHOMOLECULAR MEDICINE MARKET
FIGURE 4 GLOBAL ORTHOMOLECULAR MEDICINE MARKET, SHARE (%), BY PRODUCT TYPE, 2022
FIGURE 5 GLOBAL ORTHOMOLECULAR MEDICINE MARKET, SHARE (%), BY FORM, 2022
FIGURE 6 GLOBAL ORTHOMOLECULAR MEDICINE MARKET, SHARE (%), BY DISTRIBUTION CHANNEL, 2022
FIGURE 7 GLOBAL ORTHOMOLECULAR MEDICINE MARKET, SHARE (%), BY REGION, 2022
FIGURE 8 NORTH AMERICA: ORTHOMOLECULAR MEDICINE MARKET, SHARE (%), BY REGION, 2022
FIGURE 9 EUROPE: ORTHOMOLECULAR MEDICINE MARKET, SHARE (%), BY REGION, 2022
FIGURE 10 ASIA-PACIFIC: ORTHOMOLECULAR MEDICINE MARKET, SHARE (%), BY REGION, 2022
FIGURE 11 REST OF THE WORLD: ORTHOMOLECULAR MEDICINE MARKET, SHARE (%), BY REGION, 2022
FIGURE 12 GLOBAL ORTHOMOLECULAR MEDICINE MARKET: COMPANY SHARE ANALYSIS, 2022 (%)
FIGURE 13 ORTHO MOLECULAR PRODUCTS: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 14 ORTHO MOLECULAR PRODUCTS: SWOT ANALYSIS
FIGURE 15 ORTHOMOL PHARMAZEUTISCHE VERTRIEBS GMBH.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 16 ORTHOMOL PHARMAZEUTISCHE VERTRIEBS GMBH.: SWOT ANALYSIS
FIGURE 17 NUTRICIA NORTH AMERICA: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 18 NUTRICIA NORTH AMERICA: SWOT ANALYSIS
FIGURE 19 NUTRIHAND, INC: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 20 NUTRIHAND, INC: SWOT ANALYSIS
FIGURE 21 NATTOPHARMA.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 22 NATTOPHARMA..: SWOT ANALYSIS
FIGURE 23 CAPSUMED PHARM GMBH: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 24 CAPSUMED PHARM GMBH: SWOT ANALYSIS